Willetton Uniforms



Immusant Inc Headquarters

Looking for information about Immusant Inc Headquarters? The links below have collected all the necessary data.


ImmusanT Company Profile - Office Locations, Competitors ...

    https://craft.co/immusant
    ImmusanT's key executives are Leslie Williams, Tom Shea and Kevin Ferro. How many employees does ImmusanT have? ImmusanT has 2 employees. Who are ImmusanT competitors? Competitors of ImmusanT include ECM Therapeutics, Genclis and Human Stem Cells Institute. Where is ImmusanT headquarters? ImmusanT headquarters is located at 389 Binney St ...Employees: 2

ImmusanT - Crunchbase Company Profile & Funding

    https://www.crunchbase.com/organization/immusant
    Founded Date Jun 8, 2011. Founders Leslie Williams. Operating Status Closed. Last Funding Type Venture - Series Unknown. Legal Name ImmusanT, Inc. Company Type For Profit. Contact Email [email protected]. Phone Number 617-299-8399. ImmusanT is a biotechnology company that develops diagnostics and therapeutics for the diagnosis and treatment of ...Founder: Leslie Williams

ImmusanT Inc - Company Profile and News - Bloomberg Markets

    https://www.bloomberg.com/profile/company/0102608D:US
    ImmusanT Inc. ImmusanT Inc., is a biotechnology company. The Company studies to restore tolerance to gluten in patients with celiac disease.Leader: Thomas A Shea, Leslie J Williams

ImmusanT, Inc. LinkedIn

    https://www.linkedin.com/company/immusant-inc-
    ImmusanT, Inc. 756 followers on LinkedIn. ImmusanT is a privately held biotechnology company focused on protecting patients with celiac disease against the effects of gluten. By harnessing new ...Founded: 2010

ImmusanT - Overview, News & Competitors ZoomInfo.com

    https://www.zoominfo.com/c/immusant-inc/346491104
    ImmusanT to Present at the Jefferies 2019 Healthcare Conference CAMBRIDGE, Mass., May 29, 2019 (GLOBE NEWSWIRE) -- ImmusanT, Inc., a clinical stage company leveraging its Epitope-Specific Immuno-Therapy™ (ESIT™) platform to deliver first-in-class peptide-based immunomodulatory vaccine therapies to patients with autoimmune diseases, announced today the company’s chief executive …Employees: 18

ImmusanT 1 Kendall Sq Cambridge, MA Research Labs - MapQuest

    https://www.mapquest.com/us/massachusetts/immusant-284772103
    ImmusanT 1 Kendall Sq Cambridge MA 02139. Reviews (617) 299-8399 Website. Menu & Reservations Make Reservations . Order Online Tickets Tickets See Availability Directions {{::location.tagLine.value.text}} Sponsored Topics. Legal. Help Get directions, reviews and information for ImmusanT in Cambridge, MA. ...

ImmusanT Company Profile: Valuation & Investors PitchBook

    https://pitchbook.com/profiles/company/53480-71
    ImmusanT General Information Description. Developer of therapeutic vaccines intended to treat people with autoimmune diseases. The company's platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes, thereby enabling clinicians to improve diagnosis and medical management of autoimmune diseases.

Immunant Inc - Company Profile and News - Bloomberg Markets

    https://www.bloomberg.com/profile/company/1328475D:US
    Immunant Inc. Immunant, Inc. was founded in 2014. The company's line of business includes providing computer programming services. SECTOR. Technology. INDUSTRY. Software & Tech Services. SUB ...

ImmusanT drug trial fails in mid-stage trial - Boston ...

    https://www.bizjournals.com/boston/news/2019/07/01/expert-calls-immunsant-celiac-drug-trial-failure.html
    Jul 01, 2019 · Six months ago, biotech startup ImmusanT Inc. was toasting its new headquarters, an expanded space in Kendall Square to accommodate its growth plans …

Have you found Immusant Inc Headquarters information?

On our site you can find many other information about headquarters of any company. Research information about other companies.

Related Pages:
Recently Added Pages:
Previous Page | Next Page